GMO (Jeremy Grantham) — CVS Trade History
Quarter-by-quarter changes in the CVS HEALTH CORP position · CUSIP 126650100
Currently held · 5.8 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Reduce | 541,115 | -93,731 | -14.8% | $56.0M | 0.13% |
| 2026 Q1 | 2026-05-14 | Reduce | 634,846 | -86,272 | -12.0% | $45.6M | 0.12% |
| 2025 Q4 | 2026-02-17 | Reduce | 721,118 | -39,834 | -5.2% | $57.2M | 0.15% |
| 2025 Q3 | 2025-11-13 | Reduce | 760,952 | -91,273 | -10.7% | $57.4M | 0.16% |
| 2025 Q2 | 2025-08-13 | Reduce | 852,225 | -89,142 | -9.5% | $58.8M | 0.18% |
| 2025 Q1 | 2025-05-14 | Add | 941,367 | 165,572 | +21.3% | $63.8M | 0.20% |
| 2024 Q4 | 2025-02-13 | Reduce | 775,795 | -118,525 | -13.3% | $34.8M | 0.11% |
| 2024 Q3 | 2024-11-13 | Add | 894,320 | 4,547 | +0.5% | $56.2M | 0.18% |
| 2024 Q2 | 2024-08-13 | Add | 889,773 | 173,083 | +24.2% | $52.5M | 0.18% |
| 2024 Q1 | 2024-05-14 | Reduce | 716,690 | -65,702 | -8.4% | $57.2M | 0.21% |
| 2023 Q4 | 2024-02-13 | Reduce | 782,392 | -55,527 | -6.6% | $61.8M | 0.27% |
| 2023 Q3 | 2023-11-13 | Add | 837,919 | 36,827 | +4.6% | $58.5M | 0.28% |
| 2023 Q2 | 2023-08-14 | Add | 801,092 | 71,404 | +9.8% | $55.4M | 0.26% |
| 2023 Q1 | 2023-05-12 | Add | 729,688 | 199,400 | +37.6% | $54.2M | 0.28% |
| 2022 Q4 | 2023-02-13 | Add | 530,288 | 158,588 | +42.7% | $49.4M | 0.26% |
| 2022 Q3 | 2022-11-10 | Add | 371,700 | 47,000 | +14.5% | $35.4M | 0.20% |
| 2022 Q2 | 2022-08-12 | Add | 324,700 | 83,900 | +34.8% | $30.1M | 0.16% |
| 2022 Q1 | 2022-05-13 | Reduce | 240,800 | -61,800 | -20.4% | $24.4M | 0.12% |
| 2021 Q4 | 2022-02-11 | Reduce | 302,600 | -81,200 | -21.2% | $31.2M | 0.15% |
| 2021 Q3 | 2021-11-12 | Add | 383,800 | 17,900 | +4.9% | $32.6M | 0.16% |
| 2021 Q2 | 2021-08-12 | Add | 365,900 | 50,768 | +16.1% | $30.5M | 0.15% |
| 2021 Q1 | 2021-05-13 | Add | 315,132 | 75,632 | +31.6% | $23.7M | 0.13% |
| 2020 Q4 | 2021-02-12 | New | 239,500 | 239,500 | — | $16.4M | 0.10% |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-13 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | Sold out | — | -1,058,311 | -100.0% | — | — |
| 2017 Q4 | 2018-02-14 | Reduce | 1,058,311 | -6,700 | -0.6% | $76.7M | 0.45% |
| 2017 Q3 | 2017-11-14 | Reduce | 1,065,011 | -67,589 | -6.0% | $86.6M | 0.51% |
| 2017 Q2 | 2017-08-14 | Add | 1,132,600 | 29,310 | +2.7% | $91.1M | 0.50% |
| 2017 Q1 | 2017-05-15 | Reduce | 1,103,290 | -37,428 | -3.3% | $86.6M | 0.49% |
| 2016 Q4 | 2017-02-13 | Reduce | 1,140,718 | -3,764 | -0.3% | $90.0M | 0.48% |
| 2016 Q3 | 2016-11-10 | New | 1,144,482 | 1,144,482 | — | $101.8M | 0.48% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.